Anti-FOXO3A (phospho S253) antibody [EPR1951(2)]
- RabMAb
- Recombinant
- What is this?
5
(2 Reviews)
|
(56 Publications)
Rabbit Recombinant Monoclonal FOXO3A phospho S253 antibody. Suitable for IHC-P, Dot, WB and reacts with Human, Synthetic peptide samples. Cited in 56 publications.
View Alternative Names
FKHRL1, FOXO3A, FOXO3, Forkhead box protein O3, AF6q21 protein, Forkhead in rhabdomyosarcoma-like 1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXO3A (phospho S253) antibody [EPR1951(2)] (AB154786)
Immunohistochemical analysis of paraffin-embedded Human normal pancreas tissue labeling FOXO3A (phospho S253) with ab154786 at 1/50 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXO3A (phospho S253) antibody [EPR1951(2)] (AB154786)
Immunohistochemical analysis of paraffin-embedded Human endometrial carcinoma tissue labeling FOXO3A (phospho S253) with ab154786 at 1/50 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-FOXO3A (phospho S253) antibody [EPR1951(2)] (AB154786)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-FOXO3A (phospho S253) antibody [EPR1951(2)] (ab154786) at 1/5000 dilution
Lane 1:
MCF-7 (Human breast adenocarcinoma epithelial cell) whole cell lysates at 15 µg
Lane 2:
MCF-7 (Human breast adenocarcinoma epithelial cell) treated with IGF-1. Whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 71 kDa
Observed band size: 90 kDa
false
Exposure time: 1min
- Dot
Lab
Dot Blot - Anti-FOXO3A (phospho S253) antibody [EPR1951(2)] (AB154786)
Dot Blot analysis of Lane 1 : FOXO3A (pS253) phospho peptide and Lane 2 : FOXO3A non-phospho peptide with ab154786 at 1/1000 dilution. 5% NFDM/TBST was used as the blocking and diluting buffer and concentration. ab97051, Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated was used as the secondary antibody at 1/100000 dilution. Exposure time : 3 minutes.
Related conjugates and formulations (8)
-
Anti-FOXO3A (phospho S253) antibody [EPR1951(2)] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-FOXO3A (phospho S253) antibody [EPR1951(2)]
-
660 APC
APC Anti-FOXO3A (phospho S253) antibody [EPR1951(2)]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-FOXO3A (phospho S253) antibody [EPR1951(2)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-FOXO3A (phospho S253) antibody [EPR1951(2)]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-FOXO3A (phospho S253) antibody [EPR1951(2)]
-
578 PE
PE Anti-FOXO3A (phospho S253) antibody [EPR1951(2)]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-FOXO3A (phospho S253) antibody [EPR1951(2)]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FOXO3A acts as a regulator of genes involved in cell cycle arrest apoptosis and DNA repair. It is not part of a simple protein complex but works closely with multiple factors to influence cellular homeostasis. Significantly FOXO3A controls the expression of Bcl-2 a protein important for cell survival and the protein p27 which is important for cell cycle control. FOXO3A's activity modulates cellular longevity and impacts stress responses highlighting its abundant biological functions.
Pathways
FOXO3A integrates into the PI3K/AKT and the insulin signaling pathways both essential for cellular metabolism and proliferation control. In the PI3K/AKT pathway FOXO3A functionally links with proteins such as AKT and PTEN where its activity can be inhibited by AKT-mediated phosphorylation. In doing so it supports a balance between cell survival and apoptosis allowing the cell to adjust to growth conditions and external stressors effectively.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (56)
Recent publications for all applications. Explore the full list and refine your search
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 44:31-39 PubMed40493899
2025
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 15:3877-3899 PubMed40213661
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 11:eadr7208 PubMed40203118
2025
Applications
Unspecified application
Species
Unspecified reactive species
NPJ precision oncology 9:80 PubMed40119070
2025
Applications
Unspecified application
Species
Unspecified reactive species
BJOG : an international journal of obstetrics and gynaecology 132:107-119 PubMed39973029
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biological & pharmaceutical bulletin 47:1774-1785 PubMed39477471
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 16:685-700 PubMed38217540
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:505 PubMed36720864
2023
Applications
Unspecified application
Species
Unspecified reactive species
Developmental neuroscience 45:37-52 PubMed36470227
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature cardiovascular research 1:1195-1214 PubMed39196168
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com